Table 5 Summary of variables.
From: An economic and disease transmission model of human papillomavirus and oropharyngeal cancer in Texas
Variable | Unit | Reference | Description |
|---|---|---|---|
X | Persons | Susceptible | |
V1 | Persons | Vaccinated with 1 dose | |
V2 | Persons | Vaccinated with 2 doses | |
VS | Persons | Vaccinated with waned immunity | |
Y | Persons | Infected persons | |
U | Persons | Persistently infected | |
ZS | Persons | Recovered without seroconversion | |
Z | Persons | Recovered with seroconversion | |
WS | Persons | Infected, vaccinated with waned immunity | |
W1 | Persons | Infected, vaccinated with 1 dose | |
W2 | Persons | Infected, vaccinated with 2 doses | |
PS | Persons | Persistently infected, vaccinated | |
P1 | Persons | Persistently infected, vaccinated with 1 dose | |
P2 | Persons | Persistently infected, vaccinated with 2 doses | |
QS | Persons | Recovered, vaccinated without seroconversion | |
Q | Persons | Recovered, vaccinated with seroconversion | |
Hx | Persons | Population with tonsillectomy | |
Hy | Persons | Population with tonsillectomy that are infected | |
Hz | Persons | Population with tonsillectomy that were infected, recovered, seroconverted | |
Hzs | Persons | Population with tonsillectomy that were infected, recovered, not seroconverted | |
Hv1 | Persons | Vaccinated with 1 dose, with tonsillectomy | |
Hv2 | Persons | Vaccinated with 2 doses, with tonsillectomy | |
Hvs | Persons | Waned immunity, with tonsillectomy | |
Hw | Persons | Infected, vaccinated, with tonsillectomy | |
Hqs | Persons | Recovered, vaccinated without seroconversion, with tonsillectomy | |
Hq | Persons | Recovered, vaccinated with seroconversion, with tonsillectomy | |
N | Persons | Total number of persons | |
DOPCl | Cases/100,000 | Detected local oropharyngeal cancer | |
DOPCr | Cases/100,000 | Detected regional oropharyngeal cancer | |
DOPCd | Cases/100,000 | Detected distant oropharyngeal cancer | |
SOPC | Proportion | Oropharyngeal cancer survivors |
